• Ginsenoside Rg1: From Neuroimmune Signal to Strategy

  2026-09-07

  A translational perspective on how Ginsenoside Rg1 connects Treg-dependent gut–immune–brain restoration with more rigorous neuroprotection research, while defining the experimental controls, product-quality considerations, and boundaries required for credible advancement.

• ATRX-Deficient Glioma and RTK Inhibitor Sensitivity

  2026-09-07

  Pladevall-Morera et al. showed that high-grade glioma cells lacking ATRX are more vulnerable to selected multi-targeted receptor tyrosine kinase and PDGFR inhibitors than ATRX-proficient cells. The study also identified enhanced toxicity when these inhibitors were combined with temozolomide, supporting ATRX status as a useful stratification variable for translational glioma research and clinical-trial interpretation.

• Honokiol in CD8+ T Cell Metabolism Research

  2026-09-05

  Use Honokiol as a controlled chemical perturbation to connect NF-κB, oxidative stress, inflammation, and CD8+ T-cell metabolic assays. This workflow translates the CD28-ARS2-PKM findings into testable experiments while clearly separating established evidence from hypothesis-generating applications.

• Protease Inhibitor Cocktail for Lysosome Studies

  2026-09-04

  Learn how an EDTA-free, broad-spectrum inhibitor preserves lysosomal proteins, interactions, and phosphorylation-sensitive readouts during extraction. This practical guide connects TECPR1-mediated lysosome repair research with reproducible workflows for Western blotting, co-immunoprecipitation, pull-downs, and kinase assays.

• Batimastat (BB-94) in MMP Research

  2026-09-04

  Batimastat (BB-94) is a broad-spectrum hydroxamate MMP inhibitor for connecting extracellular proteolysis with measurable changes in matrix remodeling, neurotrophin processing, tumor invasion, and angiogenesis. This guide translates its biochemical profile into practical assay workflows while separating validated product evidence from exploratory neuromuscular-junction applications.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody Workflow

  2026-09-03

  Turn mouse primary antibodies into bright, trackable signals across immunofluorescence, flow cytometry, and western blot workflows. This practical guide shows how to apply the reagent to the renalase–PMCA4b signaling model while controlling background, photobleaching, and secondary-antibody artifacts.

• Aprotinin for RBC Membrane and Protease Assays

  2026-09-03

  Aprotinin (BPTI) gives researchers reversible control over trypsin, plasmin, and kallikrein while helping separate proteolytic artifacts from genuine red blood cell membrane mechanics. This article connects fibrinolysis inhibition and cardiovascular surgery blood management research with a practical RBC membrane workflow inspired by neutron, X-ray, and molecular-dynamics methods.

• Phillygenin in Diabetic Nephropathy

  2026-09-02

  A 2025 Phytomedicine study reports that phillygenin protects against diabetic nephropathy in high-glucose podocytes and db/db mice by coordinating suppression of TLR4/MyD88/NF-κB inflammation with activation of PI3K/AKT/GSK3β survival signaling. The work provides a mechanistic framework for linking inflammatory signaling, podocyte apoptosis, and albuminuria, while its translational value remains limited by the preclinical models and the absence of direct target-validation or clinical data.

• Gramine: A Mechanism-First TNBC Research Guide

  2026-09-02

  Gramine is an indole alkaloid and ferroptosis inducer with a distinctive CUL3–MTDH mechanism in triple-negative breast cancer research. This guide translates the underlying evidence into practical decisions for compound handling, target-engagement assays, and orthogonal ferroptosis validation.

• JNK-IN-7: Causal Apoptosis Assay Design

  2026-09-01

  JNK-IN-7 is a selective JNK inhibitor for resolving how pathogen morphology, MAPK signaling, and apoptosis intersect. This guide translates Candida krusei findings into a rigorous, pathway-aware assay strategy while defining important specificity and cross-model limitations.

• Docetaxel Workflows for Cancer Research

  2026-09-01

  Build reproducible Docetaxel assays around mitotic arrest, apoptosis, and exposure-time effects rather than relying on a single viability endpoint. This practical guide connects 2D, 3D, resistance, and xenograft workflows with troubleshooting strategies for breast, ovarian, gastric, and broader cancer chemotherapy research.

• Ibrexafungerp Activity at Vaginal pH

  2026-08-31

  The reference study examined whether acidic vaginal conditions compromise ibrexafungerp activity against 187 clinical Candida isolates, including fluconazole-resistant strains. Using standardized broth microdilution at pH 7.0 and 4.5, the authors found that ibrexafungerp maintained meaningful in vitro activity, supporting pH-aware evaluation of antifungal candidates for vulvovaginal candidiasis.

• JNK-IN-7 for JNK Signaling and Apoptosis Assays

  2026-08-31

  JNK-IN-7 is a selective JNK inhibitor for separating c-Jun-driven signaling from broader inflammatory and apoptotic responses. This workflow shows how to apply it in pathogen–host co-culture, innate immune assays, and phase-resolved apoptosis experiments while controlling for concentration-dependent pathway effects.

• Protease Inhibitor Cocktail for Mitochondrial Assays

  2026-08-30

  Protect labile mitochondrial proteins, signaling complexes, and phosphorylation-sensitive targets during extraction with an EDTA-free, broad-spectrum formulation. This workflow shows how to integrate the reagent into Western blotting, co-immunoprecipitation, kinase assays, and mechanistic studies of mitocytosis without disrupting divalent-cation-dependent biology.

• Localized BDNF Release in Early NMJ Assembly

  2026-08-29

  This study shows that muscle-derived BDNF is trafficked to podosome-like structures and released locally to organize early acetylcholine receptor clustering at developing neuromuscular junctions. By combining live-cell imaging, targeted perturbations, and muscle-specific knockout mice, the authors connect spatial BDNF processing with the initial assembly of postsynaptic apparatus.

8722 records 1/582 page Next 12345 下5页 Last page